Inventor · disambiguated record
Susanne Rauch
Also filed as: RAUCH SUSANNE
20 granted patents·18 pending applications·201 citations·filing 2015–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US11596686B2Coronavirus vaccineCureVac SE·Filed 2022·Granted Mar 7, 2023·16 cites·30 claims
- 0297US11576966B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Feb 14, 2023·16 cites·27 claims
- 0397US11471525B2Coronavirus vaccineCUREVAC AG·Filed 2021·Granted Oct 18, 2022·18 cites·29 claims
- 0497US11241493B2Coronavirus vaccineCUREVAC AG·Filed 2021·Granted Feb 8, 2022·54 cites·27 claims
- 0596US11786590B2Rotavirus vaccinesCureVac SE·Filed 2022·Granted Oct 17, 2023·5 cites·16 claims
- 0696US11413346B2Rotavirus vaccinesCUREVAC AG·Filed 2016·Granted Aug 16, 2022·12 cites·20 claims
- 0796US11141476B2MERS coronavirus vaccineCUREVAC AG·Filed 2017·Granted Oct 12, 2021·29 cites·10 claims
- 0895US11964012B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·2 cites·29 claims
- 0994US12318444B2Rotavirus vaccinesCureVac SE·Filed 2023·Granted Jun 3, 2025·1 cites·20 claims
- 1094US12168050B2Compositions comprising a norovirus nucleic acid and methods of use thereofCureVac SE·Filed 2021·Granted Dec 17, 2024·4 cites·28 claims
- 1194US11141474B2Artificial nucleic acid molecules encoding a norovirus antigen and uses thereofCUREVAC AG·Filed 2017·Granted Oct 12, 2021·31 cites·16 claims
- 1292US11918643B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2021·Granted Mar 5, 2024·6 cites·27 claims
- 1391US12097253B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Sep 24, 2024·1 cites·45 claims
- 1491US11872280B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2022·Granted Jan 16, 2024·5 cites·24 claims
- 1588US12194089B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Jan 14, 2025·1 cites·52 claims
- 1687US12390523B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·119 claims
- 1786US11964011B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·0 cites·39 claims
- 1884US12350330B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Jul 8, 2025·0 cites·42 claims
- 1981US2024091344A1Mers coronavirus vaccineCureVac SE·Filed 2023·Application pending·0 cites
- 2078US2024101608A1Optimized nucleic acid moleculesCureVac SE·Filed 2023·Application pending·0 cites
- 2177US2025288522A1LIPID NANOPARTICLE mRNA VACCINESCureVac SE·Filed 2025·Application pending·0 cites
- 2276US11865084B2MERS coronavirus vaccineCureVac SE·Filed 2021·Granted Jan 9, 2024·0 cites·14 claims
- 2376US2025152699A1Coronavirus vaccineCureVac SE·Filed 2025·Application pending·0 cites
- 2475US2024293526A1Ebolavirus and marburgvirus vaccinesCureVac SE·Filed 2024·Application pending·0 cites
- 2570US2022249654A1Nucleic acid based combination vaccinesCUREVAC AG·Filed 2022·Application pending·0 cites
- 2670US2022211841A1Nucleic acid based combination vaccinesCUREVAC AG·Filed 2022·Application pending·0 cites
- 2770US2022211838A1Nucleic acid based combination vaccinesCUREVAC AG·Filed 2022·Application pending·0 cites
- 2867US2021251898A1Lipid nanoparticle mrna vaccinesCUREVAC AG·Filed 2021·Application pending·0 cites
- 2964US2020163878A1Lipid nanoparticle mrna vaccinesCUREVAC AG·Filed 2017·Application pending·0 cites
- 3064US2020399322A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2020·Application pending·0 cites
- 3163US2025345407A1Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptideCureVac SE·Filed 2023·Application pending·0 cites
- 3262US2021170017A1Novel rsv rna molecules and compositions for vaccinationCUREVAC AG·Filed 2019·Application pending·0 cites
- 3355US2018312545A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2016·Application pending·0 cites
- 3452US2022313813A1Rotavirus mrna vaccineCUREVAC AG·Filed 2020·Application pending·0 cites
- 3550US2024066114A1Multivalent nucleic acid based coronavirus vaccinesCureVac SE·Filed 2021·Application pending·0 cites
- 3648US2021361761A1Novel yellow fever nucleic acid molecules for vaccinationCUREVAC AG·Filed 2019·Application pending·0 cites
- 3747US2017326225A1Ebolavirus and marburgvirus vaccinesCUREVAC AG·Filed 2015·Application pending·0 cites
- 3841US12508308B2Influenza mRNA vaccinesCureVac SE·Filed 2017·Granted Dec 30, 2025·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Susanne Rauch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →